{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:07:20Z","timestamp":1755907640606,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90736","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:45:03Z","timestamp":1755866703000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Recognition and Management of Arrhythmogenic Right Ventricular Cardiomyopathy in a Young Athlete: A Case Report Highlighting the Role of Multimodal Diagnosis and Preventive Implantable Cardioverter Defibrillator (ICD) Therapy"],"prefix":"10.7759","author":[{"given":"Brittni","family":"McClellan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruva","family":"Govil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky MA","year":"2009","unstructured":"Hlatky MA, Greenland P, Arnett DK, et al.. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009, 119:2408-16. 10.1161\/CIRCULATIONAHA.109.192278","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.65.2.384","article-title":"Right ventricular dysplasia: a report of 24 adult cases","volume":"65","author":"Marcus FI","year":"1982","unstructured":"Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982, 65:384-98. 10.1161\/01.cir.65.2.384","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.11.e101","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: need for an international registry","volume":"101","author":"Corrado D","year":"2000","unstructured":"Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, Wichter T. Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: need for an international registry. Circulation. 2000, 101:E101-6. 10.1161\/01.cir.101.11.e101","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv437","article-title":"EURObservational Research Programme: the chronic ischaemic cardiovascular disease registry: pilot phase (CICD-PILOT)","volume":"37","author":"Komajda M","year":"2016","unstructured":"Komajda M, Weidinger F, Kerneis M, et al.. EURObservational Research Programme: the chronic ischaemic cardiovascular disease registry: pilot phase (CICD-PILOT). Eur Heart J. 2016, 37:152-60. 10.1093\/eurheartj\/ehv437","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin JA","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ, et al.. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary. Heart Rhythm. 2019, 16:e373-407. 10.1016\/j.hrthm.2019.09.019","journal-title":"Heart Rhythm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2021.12.002","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Krahn AD","year":"2022","unstructured":"Krahn AD, Wilde AA, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, Han HC. Arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2022, 8:533-53. 10.1016\/j.jacep.2021.12.002","journal-title":"JACC Clin Electrophysiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.5.588","article-title":"Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment","volume":"83","author":"Corrado D","year":"2000","unstructured":"Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart. 2000, 83:588-95. 10.1136\/heart.83.5.588","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin JA","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ, et al.. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019, 16:e301-72. 10.1016\/j.hrthm.2019.05.007","journal-title":"Heart Rhythm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euy063","article-title":"Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia\/cardiomyopathy patient","volume":"21","author":"Wang W","year":"2019","unstructured":"Wang W, James CA, Calkins H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia\/cardiomyopathy patient. Europace. 2019, 21:9-21. 10.1093\/europace\/euy063","journal-title":"Europace"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James CA","year":"2013","unstructured":"James CA, Bhonsale A, Tichnell C, et al.. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013, 62:1290-7. 10.1016\/j.jacc.2013.06.033","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374949-early-recognition-and-management-of-arrhythmogenic-right-ventricular-cardiomyopathy-in-a-young-athlete-a-case-report-highlighting-the-role-of-multimodal-diagnosis-and-preventive-implantable-cardioverter-defibrillator-icd-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:45:03Z","timestamp":1755866703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374949-early-recognition-and-management-of-arrhythmogenic-right-ventricular-cardiomyopathy-in-a-young-athlete-a-case-report-highlighting-the-role-of-multimodal-diagnosis-and-preventive-implantable-cardioverter-defibrillator-icd-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.90736","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}